Beckman Coulter Diagnostics announced ahead of the ESCMID Global congress (formerly ECCMID) that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.
A team of researchers has discovered a new method of measuring levels of cortisol directly from a blood sample - a significant step forward in diagnosis and treatment of a wide range of diseases.
Highlights:The Access hsTnI assay provides the advanced diagnostic capabilities necessary to aid physicians in diagnosing at risk patients for acute myocardial infarction earlier and discharging non-acute patients faster.In comparison to standard troponin assays, high-sensitivity assays demonstrate significantly improved precision at and below the 99th percentile upper reference limit…
Highlights:Access PCT aids physicians in the risk assessment of critically ill patients for progression to severe sepsis or septic shock. With results you can trust in approximately 20 minutes, Access PCT allows. Access PCT allows healthcare providers to integrate procalcitonin testing into their routine sepsis workups on core laboratory analyzers as a primary or reflex test programmed…
Sample throughput: Up to 180 tests / hNo of channels: 25Assays: 68Dimensions: 1,400 × 760 × 600 mm (w × h × d)Weight: 225 kgHightlights:High throughput up to 180 tests per hourBenchtop analyzerLarge reagent capacity with 25 positionsSample rack systemSTAT laneSingle cuvette systemDual substrate and automatically switch the empty one
Sample throughput: Up to 180 tests / hNo of channels: 15Assays: 68Dimensions: 860 × 740 × 560 mm (w × h × d)Weight: 130 kgHighlights:High throughput up to 180 tests per hourOne of the smallest benchtop CLIA analyzerReagent capacity with 15 positionsSingle cuvette systemDual substrate and automatically switch the empty oneIntuitive software interface, easy access to all…
Sample throughput: Up to 240 tests / hNo of channels: 36Assays: 68Dimensions: 2,150 × 1,020 × 1,200 mm (w × h × d)Weight: 750 kgHighlights:High throughput: up to 240 tests per hourMeasurement principle: enhanced ALP-AMPPD methodReagent carousel: 36 reagent positions with non-stop refrigeratingSample handling: up to 300 samples can be loaded in one batch, sample loading and…
Sample throughput: Up to 480 tests / hNo of channels: 36Assays: 68Dimensions: 2,150 × 1,166 × 1,300 mm (w × h × d)Weight: 580 kgHighlights:Industrial highest throughput: up to 480 tests per hourMeasurement principle: enhanced ALP-AMPPD methodReagent carousel: 36 reagent positions with non-stop refrigeratingSample handling: up to 300 samples can be loaded in one batch,…
Dimensions: 1,300 × 1,250 × 890 mm (h × w × d)Weight: 460 kgSample throughput: 800-1,200 / hPower consumption: 200-240 WHighlights:Designed to meet the needs of mid- to high-volume clinical laboratories, the DxC 700 AU reduces the number of test-processing steps by 30 percent due to its intuitive user-interface that allow operators to spend less time on daily tasks…
Dimensions: 1,700 × 1,710 × 970 mm (h × w × d)Weight: 630 kgSample throughput: Up to 400 tests / hAssays: > 50 preprogrammed, bar-codedimmunoassay methodsHighlights:The UniCel DxI 800 includes proven chemiluminescent technology and one of the highest throughput systems available on the market. High-volume labs can decrease process steps and improve turnaround time by…
Dimensions: 2305 × 1150 × 1180 mm (w × h × d)(Single module + SD)Weight: 789 kg (Single module + SDM)Sample throughput: 500 tests/hSample position: 300Reagent position: 36Assays: 67Highlights:The CL-8000i is an upgraded immunoassay analyzer with high throughput up to 500T/H. CL-8000i helps improve medical quality and operational efficiency using technologies such as VU-Mix…
Dimension: CC: 2450 × 1150 × 1300 mm (w ×h × d), IM: 2305 × 1150 × 1180 mm (w × h × d)Throughput: CC: 2,000 tests/h, up to 24,00 tests/h with ISE, IM: up to 500 tests/hNumber of Parallel Tests: CC: up to 69 tests, IM: up to 36 testsHighlights:M1000 is a chemistry and immunoassay integrated system for large laboratories, with high…
Highlights:Trustable at its accuracy: PA120 is an auto specific protein analyzer with high efficiency and accuracy. Based on proven nephelometry, PA120 has great performance. Also, the large touch screen, one-press operation and multi-item combinations will offer you a fast and convenient testing experience.Currently following tests are available: HbA1c, FDP, D-Dimer, NGAL, RBP, ß2-MG,…
Dimensions: 520 × 550 × 600 mm (w × h × d)Weight: 71 kgSample throughput: 25 tests / hAssays: AFP / AFP-L3, DCPElectrokinetic Analyte Transport Assay (EATA)High sensitive fluorescence detectionAssay precision less than 3% CV for AFP-L3Increased sensitivity of liver cancer (HCC) detection by combined use of AFP, AFP-L3 and DCPUnique system to calculate the GALAD score…
Dimensions: 500 × 900 × 610 mm (h × w × d)Weight: 91 kgSample throughput: Up to 100 / hAssays: > 50 pre-programmed, bar-coded immunoassay methodsHighlights:Designed to have the robustness of a reference-lab immunoassay analyzer in the convenient size of a benchtop instrument, the Access 2 delivers quality, reliability and speed without sacrificing valuable floor space.…
Highlights:Excellent recovery thanks to low-binding propertiesRoutine-use primary container for sample collection and automated analyticsPatient-friendly sample volume of 2.5 mlCost-effective alternative to PET scanReliable pre-analytics for optimum sample integrityThe new CSF false-bottom tube (art. no.: 63.614.625) meets the requirements for reliable pre-analytics in Alzheimer’s disease…
AutoLumo A1860/A1800 is the new generation of Autobio AutoLumo Series with compact structure and innovative design, providing simpler, smarter and better user experience for small and medium size labs.
A new device that combines microfluidics on paper, electrochemical transduction and immunoassays on magnetic nanoparticles is useful for easy and rapid diagnosis of lung diseases.
Lyme disease, the most common tick-transmitted bacterial infection in the world, is challenging to diagnose. Initial early-stage symptoms may include skin rash, fever, headache, fatigue, swollen lymph nodes, and/or body and joint aches. However, these symptoms are also associated with many other diseases and medical conditions.
Dimensions: 650 × 790 × 650 mm (w × d × h)Weight: 110 kgSample throughput: up to 180 tests/hAssays: Comprehensive test menu covers SARS-CoV-2, thyroid, fertility, inflammation, cardiac markers, diabetes, tumor markers and moreHighlights:EXI 1800 is a desktop automatic chemiluminescence immunoassay analyzer with compact design which only needs 0.52 m2. With its patented…
With the rise of syndrome-style infections, co-infections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever.
Urine screening tests using only immunoassays are the most common procedures used to identify drug abuse. They are inexpensive, automated, and produce rapid results. But they may generate false-positive or false-negative results, which vary based on the drug, drug class, and the assay used. Hair toxicology analysis is another form of drug testing which, unlike urine tests, enable analysis of drug…
The speedy, high-tech method of inexpensive, accurate and high-throughput protein biomarker assay testing is being touted as a much-needed development in point-of-care (PoC) testing.
In a new study, scientists from the Hematology Department, University Hospital of Clermont-Ferrand, have successfully evaluated the analytical performance of the Yumizen G DDi 2 hemostatic immunoassay.
Accurate home testing could be used for a wider range of illnesses, as new research shows the capability of smartphone-powered tests for Dengue Fever.
The advantages and limitations of the value of traceability chains in therapeutic drug monitoring will be explored during a key session at the EuroMedLab event.
Autokit CH50 Assay is an in vitro diagnostic (IVD) test for the quantitative determination of total complement activity in human serum. The complement system is a part of the immune system that enhances/complements the ability of antibodies and phagocytic cells to clear pathogens from an organism.
Innovations in technology continue to improve clinical laboratory productivity. Total lab automation systems are responding to dramatic growth in internet-driven streamlined processes.
Considerable advances in point-of-care testing (POCT) devices are emerging from lab-on-a-chip platforms, innovations in smartphone-based technology and wearable technology. Cloud-based deep learning systems herald a future revolution.
Beckman Coulter announced the launch of an AMH test that uses a validated cut-off to aid in the assessment of poor ovarian response. This new assay helps clinicians predict poor ovarian response in those who plan to undergo controlled ovarian stimulation as part of an in vitro fertilisation (IVF) protocol.
Clinical diagnostics company Beckman Coulter announced the European launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day. The clinical laboratory has gone through trial by fire in 2020, where total testing was 245% of baseline volumes, with ~55% being SARS-CoV-2 molecular tests. Despite vaccines, many industry…
Does overcoming a SARS-CoV-2 infection protect against reinfection? The “Rhineland Study”, a population-based study conducted by DZNE in the Bonn area, is now providing new findings in this regard. Blood samples taken last year indicate that an important component of immunity – the levels of specific neutralizing antibodies against the coronavirus - had dropped in most of the study…
Siemens Healthineers announced the company's Atellica VTLi Patient-Side Immunoassay Analyzer has obtained CE mark and is expected to be available later this spring. The Atellica VTLi analyzer provides lab standard, high-sensitivity cardiac troponin I (hs-cTnI) test results to clinicians in eight minutes using a patient's fingerstick blood sample. With this industry first technology, Siemens…
Researchers investigated whether the vaccine recipients developing unusual thrombotic events and thrombocytopenia could have a prothrombotic disorder caused by platelet-activating antibodies directed against a platelet protein, as a similar mechanism is known to be caused by heparin and sometimes other environmental triggers.
Clinical diagnostics company Beckman Coulter launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE Mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection. The ability to establish a quantitative baseline to evaluate an individual’s immune response to the SARS-CoV-2 virus allows…
The new generation troponin I assay unveiled by Beckman Coulter is helping improve heart attack diagnosis. Delivering high sensitivity, and rapid result turnaround times, every element of the Access hsTnI assay has been redeveloped and updated, including the antibodies and the paramagnetic particles used. As specialists in developing and manufacturing products that simplify and automate complex…
Siemens Healthineers announced its SARS-CoV-2 IgG Antibody Test (sCOVG) has proven to measure neutralizing antibodies and has achieved CE Mark. The test is an enhanced version of the assay which became available globally this summer. It demonstrates the ability to detect neutralizing antibodies and reports quantitative results measuring the amount of neutralizing antibodies present in a patient's…
Large proportions of patients can be safely triaged either to rule out discharge or rule in lifesaving management – if following the European Society of Cardiology (ESC) Guidelines Class I recommendation of two serial measurements of hs-cTnI on admission and after one hour, if there are assay specific cut off values for the 0/1 algorithms. The Pathfast hs-cTNI assay is an approved system to…
Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR. Beckman Coulter’s IgM assay is part of a full suite of testing solutions the company is developing to…
The academic teaching Karlsruhe Hospital, at the University of Freiburg, is the largest hospital providing tertiary care in the Middle Upper Rhine Valley. Every year, 63,000 in-patients and 180,000 out-patients are treated in the 1,500-bed facility with 50 departments and 30 out-patient clinics. Inevitably, a hospital of this size has a central lab. We spoke with Dr Horst Mayer, managing senior…
Public Health England, in partnership with the University of Oxford, recently conducted a head-to-head evaluation of four commercial immunoassay tests available in the UK and used for the detection of SARS-CoV-2 antibodies.
Major weaknesses exist in the evidence base for COVID-19 antibody tests, finds a review of the latest research published by The BMJ. The evidence is particularly weak for point-of-care tests (performed directly with a patient, outside of a laboratory) and does not support their continued use, say the researchers. Serological tests to detect antibodies against COVID-19 could improve diagnosis and…
Beckman Coulter announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already shipped tests to more than 400 hospitals, clinics and diagnostics laboratories in the U.S., and has begun distribution of the new antibody test globally to countries that accept the FDA EUA and CE Mark. The…
To develop and manufacture COVID-19 test kits in massive quantities was not part of their 2020 business plans. Yet, as the epidemic evolved into a global pandemic, the urgent need for diagnostic and antibody SARS-CoV-2 test kits triggered an unprecedented scramble among medical manufacturers.
Siemens Healthineers announced today that it is now shipping worldwide its laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 IgM and IgG antibodies in blood.
Researchers at Hokkaido University have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.
Siemens Healthineers announced it is expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic.
Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK diagnostic testing laboratories and facilities in the coming weeks and months. The portal enables scientists with relevant skills and experience to volunteer their time, expertise and support for COVID-19 screening and testing.
In response to the global COVID-19 pandemic, Beckman Coulter announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high-throughput Access family of immunoassay systems, including the Access 2 and DxI series installed globally. Research has shown that after infection with SARS-CoV-2, viral…
Due to the scientific and technical developments in recombinant DNA technology and protein engineering since the early 1980s, therapeutic proteins have emerged as one of the most important classes of new pharmaceuticals. Currently, more than 200 protein and peptide based drugs have gained approval by the USA’s Food and Drug Administration (FDA) and many more are under preclinical or clinical…
Pathfast hs-cTnI is a chemi-luminescent enzyme immunoassay (CLEIA) for the quantitative measurement of cardiac troponin I (cTnI) concentration in whole blood or plasma at the point-of-care (POC). Reagents are single use in all-in-one cartridges and up to six tests in parallel can be analysed,’ the manufacturer Mitsubishi reports. ‘Low concentrations of cTnI can be analysed by using high…
Touring the laboratory at the Clínic de Barcelona Hospital, Dr José Luis Bedini revealed how the latest Siemens Healthineers technology has transformed workflow to deliver quicker results, improve efficiency, conserve energy, and thus make the team of technicians very happy! In recent months the Core Lab Operative Area at Hospital Clínic de Barcelona has undergone a transformation due to the…
At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers features in Booth #1039 its innovative IT solutions to combat the laboratory’s staffing challenges, limited budgets, and the increasing complexity in sample management and testing. “We will be demonstrating the power of our broad IT offerings and how the data they deliver, and artificial intelligence, can…
Thermo Fisher Scientific Inc. is showcasing its latest instruments, assays and software for improving speed, accuracy and usability across clinical and research labs during the 71st American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2019). Thermo Fisher is exhibiting in booth 2110 at the Anaheim Convention Center, Anaheim, Calif., August…
The critical element of testing for sepsis lies not so much in the location but in the timing and rapidity of results, according to Professor Jeannine T. Holden from Beckman Coulter Early identification enables treatment protocols to be delivered more quickly, offering better patient outcomes. Those most at risk, suggests Holden, are not patients within the intensive care unit – who are already…
The use of troponin assays to rule in or rule out myocardial infarction (MI) rapidly is critical on several levels. The quick result can reassure the patient that they have not had a heart attack and can return home safely; or, in the event of MI, the relevant treatment can start very soon. It also ensures that clinicians can make the right decision with confidence. Troponin levels have been the…
As mass spectrometry proves to be a more consistent and accurate tool in biochemical measures, with acknowledged advantages over immunoassays, its role in diagnostics has escalated. Headed by Professor Ruth Andrew, the pioneering Mass Spectrometry Core Facility at the University of Edinburgh, aims to offer researchers access to expert scientists and specialist resources to support clinical…
Liquid chromatography/mass spectrometry (LC-MS) is an established powerful tool in routine clinical use and clinical research. However, to further capitalise on its benefits, instrument and consumables vendors should continue to improve accessibility and ease-of-use, according to Dr Debadeep Bhattacharyya, senior marketing manager for clinical and forensic at Thermo Fisher Scientific. Remarkable…
As a synthetic opioid approved for treating severe pain, fentanyl has shown clear medical benefits. However, in recent years, continuous abuse of fentanyl and its derived analogues substances has become a major public health issue – overdoses and deaths associated with illicitly-manufactured fentanyl rose dramatically.
In the past, we repeatedly focused our attention on developments in the clinical application of mass spectrometry-based methods in patient care. Various aspects became significant. Today, the use of Liquid Chromatography Triple Quad Mass Spectrometry (LC-MS/MS) for therapeutic drug monitoring (TDM) can be considered today’s standard, although classically applied immunoassays continue to be…
A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Sepsis is a global healthcare crisis that affects more than 30 million people worldwide. The Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker that is…
As Shimadzu celebrates its 50th anniversary in Europe, we spoke with Stéphane Moreau, Manager of LC-MS & Life Sciences at the Marketing Europe/Analytical Business Unit of Shimadzu Europa GmbH, about today’s and many more decades of exciting clinical developments.
Beckman Coulter launched the first and only cloud-based middleware offered by a major in-vitro diagnostics organization, designed to help low-volume laboratories deliver timely results for patient care by enhancing consistency, accuracy and efficiency.
Integrated healthcare provider Primary Health Care has joined forces with Siemens Healthineers to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers. This marks Siemens Healthineers largest contract for in vitro diagnostics testing in Australia, and one of its most robust sales of the Atellica Solution. The analyzers are integrated with Atellica Diagnostics IT…
In recent years, clinicians have increasingly focused on vitamin D deficiency. Studies show that previous reference values – particularly for Vitamin D3 – were most probably set too high. Liquid chromatography with mass spectrometry (LC-MS) can help achieve more precise measurements of vitamin D levels than previously established immunoassay procedures, explains Dr Torsten Binscheck-Domass,…
Clinical laboratories need to meet greater testing demands, improve efficiency, and deliver reliable, high-quality results, while at the same time, facing an increasing shortage of skilled employees and growing budget constraints. Both patient and physician satisfaction are frequently tied to the time it takes to receive lab test results. In a recent survey commissioned by Siemens Healthineers,…
Clinical laboratories are challenged to meet greater testing demands, improve efficiency, and deliver reliable, high-quality results, while facing an increasing shortage of skilled employees and growing budget constraints. Recognizing that technology can play a critical role in addressing each of these challenges, Siemens Healthineers brought to market the Atellica Solution immunoassay and…
LC/MS, i.e. the combination of liquid chromatography (LC) with mass spectrometry (MS) – an analytical method developed primarily for environmental analysis and live science – remains a keen topic in the medical laboratory. In recent European Hospital issues, we have outlined various reasons why this procedure is in increasingly popular in the medical lab. Here we continue with an interview…
Over the last four years, Dr Thomas Stimpfl and his team have integrated mass spectrometry into routine analysis. The analytical technique liquid chromatography–mass spectrometry (LC-MS) combines the physical separation capabilities of liquid chromatography (or HPLC) with the mass analytical capabilities of mass spectrometry (MS). LC- and MS procedures were not originally developed for…
Up to the early 16th century, essentially medical diagnostics was limited to uroscopy – the observation of a urine sample in a uroscopy flask with a candle providing light. One hundred years later, the first microscopes were developed and from then on the development of technical devices and instruments boomed. Combining chromatography instruments and mass spectrometers began with the sole…
LBM Bioesterel in France, Arcispedale S. Maria Nuova in Italy and Friarage Hospital in the United Kingdom are among the first laboratories to install the Atellica Solution immunoassay and clinical chemistry analyzers. The trending motivators for installing the latest innovation from Siemens Healthineers include the unprecedented flexibility to automate redundant and complex procedures to simplify…
Up to the early 16th century, essentially medical diagnostics was limited to uroscopy – the observation of a urine sample in a uroscopy flask with a candle providing light. In a visual examination the doctor would determine the colour of the urine as well as cloudiness and precipitates, followed by a smell and taste test. The information he gathered provided the basis of his diagnosis. 100…
‘Lateral flow immunoassays (LFIs) have evolved rapidly in the past 30 years, from the original crude and simple qualitative tests, to more complex multi-analyte and quantitative assays,’ reports BBI Solutions, a firm that has been raising the performance of lateral flow tests with the development of technologies for next generation diagnostics.
BBI Solutions (BBI), immunoassay developer and reagent supplier, acquired Maine Biotechnology Services Inc. (MBS) in July 2017, adding antibody development to the firm’s end to end assay development services. This also strengthens BBI’s reagents antibodies portfolio, providing a wide range of high quality biomarkers for infectious disease.
Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.
While IA’s (Immunoassay) has been the most used technic for clinical analysis, the shift to LC-MS / MS is constantly increasing for several type of analysis like immunosuppressant, vitamin D or steroids panel, but also for several new assays including anti-coagulants, antibiotics, plasma renin activity, etc. The change from Immunoassay to LC-MS / MS could have been faster if sample…
Combining the physical separation power of liquid chromatography with the mass analysis capability of mass spectrometry – i.e. liquid chromatography tandem mass spectrometry (LC-MS/MS) – enables accurate, sensitive and selective separation, detection and identification of molecules in complex mixtures such as blood, serum and urine.
Tosoh and DiaSys announce a collaboration for clinical laboratory testing with the combination of Tosoh’s new generation analyzers (AIA-CL1200 for immunoassay and G11 for HbA1c) and DiaSys’ BioMajesty JCA-BM6010 / C. Instruments are linked through Evoline and Evoline Manager, Tosoh’s open laboratory automation and middleware solution. The collaboration addresses current requirements…
SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz System. The Topaz System is a fully integrated LC-MS platform driven by ClearCore MD, the new and intuitive…
With the combination of the basic principle of radioimmunoassay, high sensitive chemiluminescence and high specific immunoassay, the year 1977 saw the emergence of a new technology-Chemiluminescence Immunoassay (CLIA) which provided one of the best solutions for the quantification of specimens from a complex mixture with the non-radioactive nature, making it an advantage to replace RIA in…
‘Every single hour, more than 200,000 people worldwide are being diagnosed or treated with our devices,’ Michael Reitermann, COO of Siemens Healthineers, proudly reports. No reason, however, for Siemens to rest on its laurels. Quite the contrary: the company continues to drive innovation.
BBI Solutions has launched Morffi, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassaysThe technology, developed in-house by BBI Solutions scientists, improves the limit of detection of an assay, providing an increase in sensitivity of up to ten times and a faster time to result.
Siemens Healthineers unveiled the Atellica Solution(1), a highly flexible immunoassay and clinical chemistry solution featuring patented bi-directional magnetic sample-transport technology that is 10 times faster than conventional conveyors.(1)The unveiling occurred during the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia.
Cost constraints, higher workloads, and a shortage of qualified staff are three distinct market trends driving demand for greater efficiency in the laboratory. The goals of automation are to make workflow more efficient, improve the turnaround time and predictability, and reduce errors - all while accommodating future growth. Automation also frees up staff for other activities. Report: Franz Walt
Quality Control is our passion and with more than 30 years' experience developing QC for the in vitro diagnostics market we believe in producing high quality material that can help streamline procedures, whilst saving money for laboratories of all sizes and budgets. These qualities have been reflected in our RIQAS External Quality Assessment (EQA) programmes which, as outlined in Case Study 1,…
SCIEX announced today that Aarhus University Hospital in Denmark has invested in SCIEX QTRAP 6500 technology to develop novel mass spectrometry-based assays for clinical research laboratories. Scientists at the hospital’s Department of Clinical Biochemistry are using the QTRAP 6500 LC-MS/MS system for advanced clinical research, due to its exceptional sensitivity and selectivity, which are…
Today, Siemens Healthcare Diagnostics and Inpeco signed a new contract that extends the companies’ long-lasting status as preferred partners in laboratory automation. Siemens and Inpeco will be working closely together to design and deliver complex, custom solutions to help our customers meet their business and clinical needs.
Mindray is delighted to present you its latest innovations.
During the past 15 years, liquid chromatography tandem mass spectrometry (LC-MS/MS) has evolved into a vital technology used to perform routine tests in many clinical laboratories. Historically, LC-MS/MS had been used primarily by research, pharmaceutical, or commercial laboratories; however, advances in the technology, decreasing costs for basic systems, intelligible software, an increased…
Fostering a collaborative way of working won the UK’s Dartford and Gravesham NHS Trust recognition as an elite public sector healthcare employer, recently judged one of the top 100 ‘Best Places to Work’. The trust, led by chief executive Susan Acott, has created an energy-driven, patient-focused culture within the hospital, reflected by staff at all levels. This has been the driving force…
New research in The FASEB Journal suggests that clinical trials of omega-3 and antioxidant supplementation should be undertaken for people with Alzheimer's disease with mild clinical impairment.
Bringing liquid chromatography and tandem mass spectrometry (LC-MS/MS) testing into clinical laboratories has been a slow process but continues to show promise to help improve patient care. The medical device industry is on the edge of fundamental breakthroughs that can help drive the adoption into more mainstream clinical laboratories. We recently sat down with Dr Bori Shushan, Mass Spectrometry…
It’s thumbs up for Siemens Healthcare Diagnostics’ Aptio Automation, following a two-year deployment by Dundee-based National Health Service (NHS) Dundee, the first north European healthcare organisation to use the system to consolidate formerly siloed biochemistry, immunology, haematology and haemostasis testing onto a single automation track.
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies.
Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen). The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.
Automation of high-volume biochemistry and immunology laboratories has been on-going for more than a decade, yet central laboratories only recently dared to take on the daunting task of automating the more complex processes of microbiology. Report: John Brosky
We are seeing great priority shifts in China’s funding for R&D and manufacturing expansion. Even the agency responsible for selecting the recipients has changed, Jie Ren reports from the Beijing-based market analysis consultancy Whitney Research Inc. Report: John Brosky
The University Medical Center in Utrecht (UMCU), The Netherlands, is in the process of creating a multidisciplinary centre of excellence, able to manage resources efficiently while delivering the highest level of patient care and clinical research.
Health analysts have predicted that DNA sequencing will shift from a laboratory-based setup to point of care testing within the next five years.
On the leading edge of automation for medical laboratory testing, Siemens Healthcare rolled out an impressive suite of new products at IFCC WorldLab 2014 in Istanbul, Turkey that are ‘exactly aligned, and even anticipate, customer needs in central lab operations,’ according to Franz Walt, CEO for the Chemistry, Immunoassay, Automation and Diagnostics IT business unit within Siemens’…
As many laboratories face demands to turn around faster, more accurate patient test results against a backdrop of increasingly stringent quality control and tighter budgets, the search is on for tools to help meet ever-stretching targets.
Most clinical laboratories use immunoassays routinely to measure 25-hydroxyvitamin D (25OH D) in serum. The metabolites of vitamin D are important in the regulation of calcium and bone metabolism.
New Assay Is First to Standardize to World Health Organization’s 5th International Standard for Chorionic Gonadotropin
Beckman Coulter’s new Access AccuTnI+3 troponin I assay has received FDA clearance for its UniCel DxI series of immunoassay systems at the same time as having a new CE Mark approved on the UniCel DxI and Access 2 immunoassay instruments.
Snibe, the Shenzhen New Industries Biomedical Engineering Company Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and in vitro reagents. Founded 18 years ago and a growing force in the Chinese market, the firm is based in Shenzhen, China’s fourth largest city, situated in Guangdong Province.
Labs need to optimise their costs as well as accommodate increasing volumes – and new tests are continuously demanded.
Snibe, Shenzhen New Industries Biomedical Engineering Co., Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and reagents.
Demand is increasing for point of care (POC) diagnostic testing, particularly for tests that help foster clinical decision-making within 30 minutes or less.
Inadequate testing may mean one of the most common healthcare-acquired infections could go undiagnosed.
Siemens Healthcare Diagnostics launched Aptio™ Automation¹, the company’s next generation laboratory automation platform, at the 2012 AACC and ASCLS Annual Meetings and Clinical Lab Expo in Los Angeles, July 15 – 19 (Booth #1701). Aptio Automation promises to transform laboratory operations by combining Siemens’ industry-leading workflow expertise with peak performance, adaptability and…
Molecular diagnostics is one of the most important technological advances in clinical diagnostics, seeing the €3.6 billion market grow 10% in constant currency (CC) in 2010 and predicted continual growth well above the diagnostic industry rates. The recipe for success in this field lies in three critical components: core technology, automation and menu. During our interview with Marc Meyer, the…
Devised by the European Liver Test group, the new, non-invasive Enhanced Liver Fibrosis (ELF) test on Siemens ADVIA Centaur Immunoassay Systems can identify, in under an hour, bloodbased biomarkers to detect the amount of fibrosis in the liver.
To gain a deeper understanding of Asian and especially South Korean innovations in the healthcare market EUROPEAN HOSPITAL visited the 28th Korea International Medical and Hospital Equipment Show (KIMES) on 16 to 19 February. Executive Director Daniela Zimmermann had the opportunity to speak with Jae-Moon Jo, team leader in medical equipment development and Senior Vice President of Samsung…
The health of the laboratory/ clinician relationship has always served as a good indicator of the overall quality of a given healthcare network. Historically, labs focused ‘heads down’ on delivering excellent test results, but today appear to be expanding their horizons to partner with clinicians for better patient care.
Siemens Healthcare Diagnostics announced today that its ADVIA Centaur® Syphilis Assay1 for the detection of antibodies against Treponema pallidum, a bacterium known to cause the sexually-transmitted disease, syphilis, has been CE-marked. Now, laboratories outside the United States can equip themselves with a new testing tool for this serious condition and drive additional workflow and efficiency…
During the IFCC and EuroMedLab congress in Berlin, Beckmann Coulter launched into Europe its AU 5800, which, the firm reports, improves processing time compared to current systems and therefore meets the demands of ever faster workflow in clinical laboratories.
Following CE mark registration to sell a fully-automated Mycophenolic acid (MPAT) test for use on the Dimension integrated chemistry systems*, Siemens Healthcare Diagnostics has become the first to offer the consolidation of four fully-automated immunosuppressant drug (ISD) tests -- Mycophenolic acid, Cyclosporine, Tacrolimus and Sirolimus – used to monitor organ transplant patients.
Southampton University Hospitals’ Department of Laboratory Medicine has recently transformed the way it delivers its pathology service, becoming one of the largest automation installations in the National Health Service to operate under a managed service contract. This has contributed significantly to the development of a strengthened and expanded pathology network across Southern England.
USA - Over the past couple of decades, due to acquisitions California-based Beckman Coulter Inc has became one of the world’s largest manufacturers of in vitro diagnostics analysers and automation for clinical pathology laboratories. Now, in a US$6.8 billion transaction, including debt and cash acquired, the company itself been acquired by the Danaher Corporation of Washington, D.C.
Improvements in microfluidics and detection technologies are beginning to expand the range of point-of-care diagnostics beyond simple blood chemistry tests to sophisticated immuno-assays and molecular diagnostics. Though yet to see much adoption in European hospitals, these point-of-care (POC) diagnostics are coming into use in the USA, initially in emergency rooms and ICUs where fast results are…
The world consists of molecules – so do we. With the progression of measurement tools such as microscopes, centrifuges, or spectrometers, mankind is becoming better and better in identifying the substances from which our world is made. Today, with the technical developments in mass spectrometry, biomolecules can be weighted with the highest precision and accuracy ever known, placing it among…
Current cervical cancer screening is time consuming and expensive, but now new breakthrough technology developed by European researchers should allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost.
California, USA: 20,000 visitors and 700 manufacturers showing products in almost 2000 booths at the American Association for Clinical Chemistry (AACC) annual meeting (July 5-29, 2010) underlined the importance of this, the world’s largest gathering of clinical laboratory professionals.
St Jude Medical Center, in Fullerton, California, has always taken pride in its reputation as one of Southern California’s most respected and technologically advanced hospitals. With 384 licensed beds and over 700 physicians the centre offers a comprehensive array of services and programmes, including cardiac, stroke care, a breast and cancer centres, full maternity services, orthopaedic…
The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality was given a boost in 2009 when the conclusive findings from the 10-year European Randomized Study of Screening for Prostate Cancer (ERSPC) -- the world’s largest prostate cancer screening study – were published.
The newest laboratory system from Ortho Clinical Diagnostics is a big success: 32 VITROS 3600 immunoassay systems are going to be used in 15 of a total of 21 blood banks in Poland in the future. They will enable roughly 800,000 blood tests to be carried out each year. This next-generation diagnosis platform is based on VITROS technologies, the best in the world, thus meeting the demands of modern…
This year's AACC, held in conjunction with the Canadian Society for Clinical Chemists, and the Annual Meeting of the American Society for Clinical Laboratory Science, featured around 200 educational sessions and drew in over 18,000 delegates and exhibitors from almost 100 countries.
Beckman Coulter, Inc. has expanded its drugs of abuse test menu to include a DRI* Oxycodone Enzyme Immunoassay (OXYX). The assay is for the qualitative and semi-quantitative determination of oxycodone and its metabolite, oxymorphone, in human urine.
Beckman Coulter Inc, manufacturer of medical test systems, has agreed to acquire the diagnostic systems portion of Olympus Corporation's life sciences business.
Beckman Coulter, Inc., a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, and Olympus Corporation, a Tokyo-headquartered precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, announced today that they have entered into a definitive agreement…
Marcel van Kasteel MBA, is VP of Philips and CEO of Handheld Immunoassays, a Philips Incubator venture in Eindhoven, the Netherlands, which recently announced that, by the end of this year, the first device to test for drug abuse will be marketed that will make on the spot testing simple and quick for use by the police.
A new lab-on-chip system, the ivD-platform, which quickly determines, on site, the contents and parameters of biological samples, such as blood or saliva, with the help of immunoassay or DNA analysis, was presented at Biotechnica this autumn.
bioMérieux, a world leader in the field of in vitro diagnostics (IVD), offers the most comprehensive diagnostic solution on the market to help hospitals and healthcare facilities fight Healthcare-Associated Infection (HAI).
This summer, California-based Beckman Coulter Inc. began general distribution of its UniCel DxC 880i's integrated system in Europe.
It runs and runs and runs The Olympus AU640 clinical chemistry analyser is the most reliable analyser considering a period of 12 months. This is the result published in the NHS Purchasing and Supply Agency Analyser Monitoring Programme Annual Report 2006-2007.
The future of the in vitro diagnostics (IVD) market looks promising. According to a new analysis from Frost & Sullivan, Western European IVD Market is estimated to reach $12.65 billion in 2014. The reason: Diseases depending on an aging population, such as infections, hike the demand for automated diagnostic tools.
Barcelona, Spain - The Hospital Clinic is a tertiary level University Hospital that provides a broad range of services, from basic healthcare coverage to 550,000 people, to academic and advanced research activities. Hospital Clinic is a leading institution in certain pathologies, being the reference for Spain in different areas.
Inverness Medical acquired the Determine Brand of diagnostics was from Abbott laboratories in 2005. This move was part of their ongoing strategy to provide clinicians worldwide with a comprehensive portfolio of rapid, potentially life-saving diagnostic tools.
San Diego, California - 20,000 international physicians, scientists and other visitors travelled to the Annual Meeting & Clinical Lab Expo of the American Association for Clinical Chemistry (AACC) in July, and 750 exhibitors emphasised the increasing importance of this gathering
By Paolo Montuschi MD, of the Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Beckman Coulter, Inc. has launched the next analyser in its series of in vitro diagnostic offerings, the UniCel® DxI 600 Access® Immunoassay System, an innovative immunochemistry instrument designed for mid-volume laboratories, a segment which represents more than 45 percent of the immunodiagnostic testing market, worldwide.
Beckman Coulter has launched the next analyzer in its growing family of UniCel® systems, the UniCel DxI 600 Access® Immunoassay System. This instrument is designed for mid-volume laboratories, a segment which represents more than 45 percent of the immunodiagnostic testing market, worldwide.
Siemens Medical Solutions strengthens its diagnostics devision, J&J wins stent patent appeal over Boston Scientific and Medtronic, Leica extends its product range and GE Healthcare cooperates with Ludwig-Maximilian-Universität in Munich as a reference center and strategic partner in developing cell-based assay modes.
Advia LabCell Modular Automation Systems integrate clinical chemistry, immunodiagnostics, haematology, urinalysis, and other hospital and laboratory areas.
Beckman Coulter developed a new integrated lab systems: The UniCel DxC880i prototype should deliver efficient disease management services.
Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.
In preparation for EU entry, Romania's laboratories are in the process of raising standards.
Access and monitoring of multiple lab instruments from a centralised location.
The fundamental role of inflammation in almost all disease processes has been increasingly recognised over several years.
The development of diagnostic products and systems has paralleled the development of new technologies in fields such as biology, electronics and computer science.
Clinical chemistry has evolved far beyond its beginnings of blood and urine analysis. Advanced techniques such as enzyme measurement, electrophoresis, and immunoassays have made their impact on the field, expanding its diagnostic capabilities. Keep reading for advances in automation and clinical chemistry applications for toxicology, urinalysis and much more.